research glp 1 Discovery of GLP-1–Based Drugs for the Treatment of Obesity Researchers at UC Irvine issue

Pregnant women exposed to these medications and healthcare providers are encouraged to report exposures: For Semaglutide: Contact Novo Nordisk at 1-877-390-2760 or [www.wegovypregnancyregistry.com]( For Tirzepatide: Contact Eli Lilly and Company at 1-800-LillyRx (1-800-545-5979) Please note that the above list is not complete, and it describes the most common side effects and risks

I hope that other states will follow suit and together we can push back against greedy health care behemoths and create real relief for our residents. NASHP is a bipartisan network that brings senior state level policy leaders together from around the country

Santosa, S., & Jensen, M

Important: GLP1s are not safe in pregnancy

In vitro CYP450 enzyme down-regulation by GLP-1/glucagon co-agonist does not translate to observed drug-drug interactions in the clinic

Semaglutide GLP-1, a revolutionary medication in the management of type 2 diabetes and weight loss , perfectly complements our holistic approach to health, providing patients with innovative solutions for better living